Introduction Dementia imposes significant care and financial burdens on families and countries globally. While high-quality home-based care is crucial, the current supply chain of care - relying on family caregivers and community healthcare workers - remains fragmented and lacks effective integration.
Furthermore, although artificial intelligence (AI) holds promise, existing applications predominantly focus on diagnosis or monitoring rather than holistic care delivery and quality of life (QoL). This study aims to evaluate the effectiveness of the community home-based dual-supplier cooperation (CHDSC) care model in older people with dementia.
Methods and analysis A 1-year, assessor-blinded, parallel-group, superiority randomised controlled trial with 1:1 allocation will be conducted. A total of 200 pairs (community-dwelling people with dementia aged ≥65 years and their primary family caregivers) will be recruited from four community health centres in Guangzhou, China, and randomly assigned to either the CHDSC care model intervention or usual care.
BMJ Open published a clinical update in Research Highlights on 27 Apr 2026.
The item focuses on Development of a community home-based dual-supplier cooperation care model for people with dementia based on an intelligent decision-assistance system: protocol of a 1-year randomised controlled trial in China.
Review the original article for the full source wording and details.